ACRS logo

Aclaris Therapeutics (ACRS) Working Capital

Annual Working Capital

$97.90 M
-$111.71 M-53.29%

December 31, 2023


Summary


Performance

ACRS Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRSbalance sheetmetrics:

Quarterly Working Capital

$113.51 M
+$11.56 M+11.34%

September 30, 2024


Summary


Performance

ACRS Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRSbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

ACRS Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-53.3%+18.6%
3 y3 years+129.7%-39.6%
5 y5 years-35.7%+6.7%

ACRS Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.3%at low-53.3%+18.6%
5 y5-year-53.3%+129.7%-53.3%+166.3%
alltimeall time-53.3%+652.0%-53.3%+1158.5%

Aclaris Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$113.51 M(+11.3%)
Jun 2024
-
$101.95 M(-11.5%)
Mar 2024
-
$115.26 M(+17.7%)
Dec 2023
$97.90 M(-53.3%)
$97.90 M(+2.3%)
Sep 2023
-
$95.75 M(-13.0%)
Jun 2023
-
$110.11 M(-33.7%)
Mar 2023
-
$166.10 M(-20.8%)
Dec 2022
$209.61 M(+15.1%)
$209.61 M(-11.5%)
Sep 2022
-
$236.78 M(-2.6%)
Jun 2022
-
$243.14 M(+39.6%)
Mar 2022
-
$174.16 M(-4.4%)
Dec 2021
$182.10 M(+327.3%)
$182.10 M(-3.1%)
Sep 2021
-
$187.94 M(-17.0%)
Jun 2021
-
$226.34 M(+88.6%)
Mar 2021
-
$120.00 M(+181.6%)
Dec 2020
$42.62 M(-30.6%)
$42.62 M(-5.7%)
Sep 2020
-
$45.21 M(-15.0%)
Jun 2020
-
$53.21 M(-14.3%)
Mar 2020
-
$62.11 M(+1.2%)
Dec 2019
$61.37 M
$61.37 M(-42.3%)
DateAnnualQuarterly
Sep 2019
-
$106.38 M(+11.8%)
Jun 2019
-
$95.15 M(-21.1%)
Mar 2019
-
$120.58 M(-20.7%)
Dec 2018
$152.16 M(-18.8%)
$152.16 M(+23.5%)
Sep 2018
-
$123.24 M(-18.4%)
Jun 2018
-
$151.10 M(-15.3%)
Mar 2018
-
$178.43 M(-4.8%)
Dec 2017
$187.46 M(+41.7%)
$187.46 M(-16.4%)
Sep 2017
-
$224.13 M(+33.9%)
Jun 2017
-
$167.38 M(+10.3%)
Mar 2017
-
$151.71 M(+14.6%)
Dec 2016
$132.33 M(+55.7%)
$132.33 M(+63.4%)
Sep 2016
-
$81.00 M(-10.1%)
Jun 2016
-
$90.13 M(+8.5%)
Mar 2016
-
$83.10 M(-2.2%)
Dec 2015
$84.97 M(+470.9%)
$84.97 M(+126.8%)
Sep 2015
-
$37.46 M(+315.3%)
Jun 2015
-
$9.02 M(-39.4%)
Dec 2014
$14.88 M(+14.3%)
$14.88 M
Dec 2013
$13.02 M
-

FAQ

  • What is Aclaris Therapeutics annual working capital?
  • What is the all time high annual working capital for Aclaris Therapeutics?
  • What is Aclaris Therapeutics annual working capital year-on-year change?
  • What is Aclaris Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Aclaris Therapeutics?
  • What is Aclaris Therapeutics quarterly working capital year-on-year change?

What is Aclaris Therapeutics annual working capital?

The current annual working capital of ACRS is $97.90 M

What is the all time high annual working capital for Aclaris Therapeutics?

Aclaris Therapeutics all-time high annual working capital is $209.61 M

What is Aclaris Therapeutics annual working capital year-on-year change?

Over the past year, ACRS annual working capital has changed by -$111.71 M (-53.29%)

What is Aclaris Therapeutics quarterly working capital?

The current quarterly working capital of ACRS is $113.51 M

What is the all time high quarterly working capital for Aclaris Therapeutics?

Aclaris Therapeutics all-time high quarterly working capital is $243.14 M

What is Aclaris Therapeutics quarterly working capital year-on-year change?

Over the past year, ACRS quarterly working capital has changed by +$17.77 M (+18.55%)